Business Daily from THE HINDU group of publications
Thursday, Dec 21, 2006
ePaper
Business Daily from THE HINDU group of publications Thursday, Dec 21, 2006 ePaper |
|
|
|
|
|
|
|
Corporate
-
New Projects Markets - IPOs Our Bureau
Mumbai , Dec. 20 Alpa Laboratories Ltd, a pharmaceuticals formulations company, has filed a draft prospectus with SEBI to enter the capital market with an IPO of 95 lakh equity shares of Rs 10 each through a 100 per cent book building process. Of the shares on offer, 2.50 lakh shares will be reserved for employees and the net offer to the public will be 92.50 lakh shares. Fifty per cent is being reserved for qualified institutional bidders and 15 per cent for non-institutional investors. The remaining 35 per cent is reserved for allotment to retail investors on a proportionate basis. The issue will constitute 44.06 per cent of the fully diluted post-issue equity capital of the company. The lead manager for the issue is Allianz Securities Ltd and the registrar will be Bigshare Services. The company is also expanding its existing production capacity and widening its product range by entering into segments such as probiotics, prebiotics and pre-filled syringes. For the proposed expansion, the company is setting up a new plant at Pigdamber, Indore in Madhya Pradesh at a cost of Rs 42.35 crore.
More Stories on : New Projects | IPOs | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2006, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|